Inflammasome-Independent NLRP3 Restriction of a Protective Early Neutrophil Response to Pulmonary Tularemia

PLoS Pathogens

Volumn 12, Issue 12, 2016, Pages

  Periasamy, Sivakumar ^a   Le, Hongnga T ^a   Duffy, Ellen B ^a   Chin, Heather ^a   Harton, Jonathan A ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; CRYOPYRIN; IMMUNOGLOBULIN M ANTIBODY; INFLAMMASOME; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 1BETA CONVERTING ENZYME; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MEMBRANE PROTEIN; NECROSTATIN; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; NLRP3 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL INFECTION; BLOOD SAMPLING; BONE MARROW CELL; BRONCHOALVEOLAR LAVAGE FLUID; CELL DEATH; CONTROLLED STUDY; DISEASE PREDISPOSITION; FEMALE; FLOW CYTOMETRY; FRANCISELLA; FRANCISELLA NOVICIDA; FRANCISELLA TULARENSIS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MACROPHAGE; MALE; MOLECULAR PATHOLOGY; MOUSE; NEUTROPHIL; NONHUMAN; PULMONARY TULAREMIA; STROMA CELL; ADOPTIVE TRANSFER; ANIMAL; BACTERIAL PNEUMONIA; C57BL MOUSE; DISEASE MODEL; IMMUNOLOGY; TRANSGENIC MOUSE; TULAREMIA;

ADOPTIVE TRANSFER; ANIMALS; DISEASE MODELS, ANIMAL; FLOW CYTOMETRY; FRANCISELLA TULARENSIS; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; INFLAMMASOMES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; NEUTROPHILS; NLR FAMILY, PYRIN DOMAIN-CONTAINING 3 PROTEIN; PNEUMONIA, BACTERIAL; TULAREMIA;

EID: 85007579447     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1006059     Document Type: Article

References (63)

1. Lamps L.W., Havens J.M., Sjostedt A., Page D.L., Scott M.A, Histologic and molecular diagnosis of tularemia: a potential bioterrorism agent endemic to North America. Mod. Pathol. 2004; 17: 489–;495. doi: 10.1038/modpathol.380008715001997
2. Sjostedt A, Intracellular survival mechanisms of Francisella tularensis, a stealth pathogen. Microbes. Infect. 2006; 8, 561–;567. doi: 10.1016/j.micinf.2005.08.00116239121
3. Kingry L.C., Petersen J.M, Comparative review of Francisella tularensis and Francisella novicida. Front Cell Infect Microbiol. 2014;4:35. doi: 10.3389/fcimb.2014.0003524660164
4. Periasamy S., Avram D., Mccabe A., Macnamara K.C., Sellati T.J., Harton J.A, An Immature Myeloid/Myeloid-Suppressor Cell Response Associated with Necrotizing Inflammation Mediates Lethal Pulmonary Tularemia. PLoS Pathog. 2016;12(3):e1005517. doi: 10.1371/journal.ppat.100551727015566
5. Wickstrum J.R., Bokhari S.M., Fischer J.L., Pinson D.M., Yeh H.W., Horvat R.T., et al. Francisella tularensis induces extensive caspase-3 activation and apoptotic cell death in the tissues of infected mice. Infect Immun. 2009;77(11):4827–;36. doi: 10.1128/IAI.00246-0919703976
6. Parmely M. J., Fischer J. L., Pinson D. M, Programmed cell death and the pathogenesis of tissue injury induced by type A Francisella tularensis. FEMS Microbiol. Lett. 2009; 301: 1–;11. doi: 10.1111/j.1574-6968.2009.01791.x19811540
7. Bosio C.M., Bielefeldt-ohmann H., Belisle J.T, Active suppression of the pulmonary immune response by Francisella tularensis Schu4. J Immunol. 2007;178(7):4538–;47. 17372012
8. Mares C.A., Ojeda S.S., Morris E.G., Li Q., Teale J.M, Initial delay in the immune response to Francisella tularensis is followed by hypercytokinemia characteristic of severe sepsis and correlating with upregulation and release of damage-associated molecular patterns. Infect Immun. 2008;76(7):3001–;10. doi: 10.1128/IAI.00215-0818411294
9. Telepnev M., Golovliov I., Grundström T., Tärnvik A., Sjöstedt A, Francisella tularensis inhibits Toll-like receptor-mediated activation of intracellular signalling and secretion of TNF-alpha and IL-1 from murine macrophages. Cell Microbiol. 2003;5(1):41–;51. 12542469
10. Medina E.A., Morris I.R., Berton M.T, Phosphatidylinositol 3-kinase activation attenuates the TLR2-mediated macrophage proinflammatory cytokine response to Francisella tularensis live vaccine strain. J Immunol. 2010;185(12):7562–;72. doi: 10.4049/jimmunol.090379021098227
11. Cowley S.C., Goldberg M.F., Ho J.A., Elkins K.L, The membrane form of tumor necrosis factor is sufficient to mediate partial innate immunity to Francisella tularensis live vaccine strain. J Infect Dis. 2008;198(2):284–;92. doi: 10.1086/58962018593295
12. Kurtz S.L., Foreman O., Bosio C.M., Anver M.R., Elkins K.L, Interleukin-6 is essential for primary resistance to Francisella tularensis live vaccine strain infection. Infect Immun. 2013;81(2):585–;97. doi: 10.1128/IAI.01249-1223230288
13. Del barrio L., Sahoo M., Lantier L., Reynolds J.M., Ceballos-olvera I., Re F, Production of anti-LPS IgM by B1a B cells depends on IL-1β and is protective against lung infection with Francisella tularensis LVS. PLoS Pathog. 2015;11(3):e1004706. doi: 10.1371/journal.ppat.100470625768794
14. Mariathasan S., Weiss D.S., Dixit V.M., Monack D.M, Innate immunity against Francisella tularensis is dependent on the ASC/caspase-1 axis. J Exp Med. 2005;202(8):1043–;9. doi: 10.1084/jem.2005097716230474
15. Li H., Nookala S., Bina X.R., Bina J.E., Re F, Innate immune response to Francisella tularensis is mediated by TLR2 and caspase-1 activation. J Leukoc Biol. 2006;80(4):766–;73. doi: 10.1189/jlb.040629416895974
16. Henry T., Monack D.M, Activation of the inflammasome upon Francisella tularensis infection: interplay of innate immune pathways and virulence factors. Cell Microbiol. 2007;9(11):2543–;51. doi: 10.1111/j.1462-5822.2007.01022.x17662071
17. Fernandes-alnemri T., Yu J.W., Juliana C., Solorzano L., Kang S., Wu J., et al. The AIM2 inflammasome is critical for innate immunity to Francisella tularensis. Nat Immunol. 2010;11(5):385–;93. doi: 10.1038/ni.185920351693
18. Jones J.W., Kayagaki N., Broz P., Henry T., Newton K., O’Rourke K, et al. Absent in melanoma 2 is required for innate immune recognition of Francisella tularensis. Proc Natl Acad Sci USA. 2010;107(21):9771–;6. doi: 10.1073/pnas.100373810720457908
19. Rathinam V.A., Jiang Z., Waggoner S.N., Sharma S., Cole L E., Waggoner L., et al. The AIM2 inflammasome is essential for host defense against cytosolic bacteria and DNA viruses. Nature Immunol. 2010; 11, 395–;402.
20. Hornung V., Ablasser A., Charrel-dennis M., Bauernfeind F., Horvath G., Caffrey D.R., et al. AIM2 recognizes cytosolic dsDNA and forms a caspase-1-activating inflammasome with ASC. Nature. 2009;458(7237):514–;8. doi: 10.1038/nature0772519158675
21. Schroder K., Tschopp J, The inflammasomes. Cell. 2010;140(6):821–;32. doi: 10.1016/j.cell.2010.01.04020303873
22. Atianand M.K., Duffy E.B., Shah A., Kar S., Malik M., Harton J.A, Francisella tularensis reveals a disparity between human and mouse NLRP3 inflammasome activation. J Biol Chem. 2011;286(45):39033–;42. doi: 10.1074/jbc.M111.24407921930705
23. Ting J.P., Willingham S.B., Bergstralh D.T, NLRs at the intersection of cell death and immunity. Nat Rev Immunol. 2008;8(5):372–;9. doi: 10.1038/nri229618362948
24. Martinon F, Mayor A, Tschopp J, The inflammasomes: guardians of the body. Annu Rev Immunol. 2009;27:229–;65. doi: 10.1146/annurev.immunol.021908.13271519302040
25. Anand P.K., Malireddi R.K., Kanneganti T.D, 2011. Role of the nlrp3 inflammasome in microbial infection. Front Microbiol2:12. doi: 10.3389/fmicb.2011.0001221687408
26. Storek K.M., Monack D.M, Bacterial recognition pathways that lead to inflammasome activation. Immunol Rev. 2015;265(1):112–;29. doi: 10.1111/imr.1228925879288
27. Huang M.T., Mortensen B.L., Taxman D.J., Craven R.R., Taft-Benz S., Kijek T.M., et al. Deletion of ripA alleviates suppression of the inflammasome and MAPK by Francisella tularensis. J Immunol. 2010;185(9):5476–;85. doi: 10.4049/jimmunol.100215420921527
28. Dotson R.J., Rabadi S.M., Westcott E.L., Bradley S., Catlett S.V., Banik S., et al. 2013. Repression of inflammasome by Francisella tularensis during early stages of infection. J Biol Chem. 2013;288(33):23844–;57. doi: 10.1074/jbc.M113.49008623821549
29. Mariathasan S., Weiss D.S., Newton K., McBride J., O’Rourke K., Roose-Girma M., et al. Cryopyrin activates the inflammasome in response to toxins and ATP. Nature. 2006;440(7081):228–;32. doi: 10.1038/nature0451516407890
30. Dinarello C.A, Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol. 2009;27:519–;50. doi: 10.1146/annurev.immunol.021908.13261219302047
31. Coll R.C., et al., A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases. Nat Med. 2015; 21(3):248–;55doi: 10.1038/nm.380625686105
32. Sjöstedt A., Conlan J.W., North R.J, Neutrophils are critical for host defense against primary infection with the facultative intracellular bacterium Francisella tularensis in mice and participate in defense against reinfection. Infect Immun. 1994;62(7):2779–;83. 8005668
33. Conlan J.W., Kuolee R., Shen H., Webb A, Different host defences are required to protect mice from primary systemic vs pulmonary infection with the facultative intracellular bacterial pathogen, Francisella tularensis LVS. Microb Pathog. 2002;32(3):127–;34. doi: 10.1006/mpat.2001.048911855943
34. Conlan J.W., Sjöstedt A., North R.J, CD4+ and CD8+ T-cell-dependent and -independent host defense mechanisms can operate to control and resolve primary and secondary Francisella tularensis LVS infection in mice. Infect Immun. 1994;62(12):5603–;7. 7960142
35. Cowley S.C., Elkins K.L, Multiple T cell subsets control Francisella tularensis LVS intracellular growth without stimulation through macrophage interferon gamma receptors. J Exp Med. 2003;198(3):379–;89. doi: 10.1084/jem.2003068712885873
36. Elkins K.L., Cowley S.C., Bosio C.M, Innate and adaptive immune responses to an intracellular bacterium, Francisella tularensis live vaccine strain. Microbes Infect. 2003;5(2):135–;42. 12650771
37. Griffith J.W., Sokol C.L., Luster A.D, Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol. 2014;32:659–;702. doi: 10.1146/annurev-immunol-032713-12014524655300
38. Willingham S.B., Bergstralh D.T., O'Connor W., Morrison A.C., Taxman D.J., Duncan J.A., et al. Microbial pathogen-induced necrotic cell death mediated by the inflammasome components CIAS1/cryopyrin/NLRP3 and ASC. Cell Host Microbe. 2007;2(3):147–;59. doi: 10.1016/j.chom.2007.07.00918005730
39. Willingham S.B., Allen I.C., Bergstralh D.T., Brickey W.J., Huang M.T., Taxman D.J., et al. NLRP3 (NALP3, Cryopyrin) facilitates in vivo caspase-1 activation, necrosis, and HMGB1 release via inflammasome-dependent and -independent pathways. J Immunol. 2009;183(3):2008–;15. doi: 10.4049/jimmunol.090013819587006
40. Huang M.T., Taxman D.J., Holley-guthrie E.A., Moore C.B., Willingham S.B., Madden V., et al. Critical role of apoptotic speck protein containing a caspase recruitment domain (ASC) and NLRP3 in causing necrosis and ASC speck formation induced by Porphyromonas gingivalis in human cells. J Immunol. 2009;182(4):2395–;404. doi: 10.4049/jimmunol.080090919201894
41. Broz P., Von moltke J., Jones J.W., Vance R.E., Monack D.M, Differential requirement for Caspase-1 autoproteolysis in pathogen-induced cell death and cytokine processing. Cell Host Microbe. 2010;8(6):471–;83. doi: 10.1016/j.chom.2010.11.00721147462
42. Wong K.W., Jacobs W.R, Critical role for NLRP3 in necrotic death triggered by Mycobacterium tuberculosis. Cell Microbiol. 2011;13(9):1371–;84. doi: 10.1111/j.1462-5822.2011.01625.x21740493
43. Inoue Y., Shirasuna K., Kimura H., Usui F., Kawashima A., Tago K., et al. NLRP3 regulates neutrophil functions and contributes to hepatic ischemia-reperfusion injury independently of inflammasomes. J Immunol. 2014;192(9):4342–;51. doi: 10.4049/jimmunol.130203924696236
44. Lai X.H., Sjöstedt A, Delineation of the molecular mechanisms of Francisella tularensis-induced apoptosis in murine macrophages. Infect Immun. 2003;71(8):4642–;6. doi: 10.1128/IAI.71.8.4642-4646.200312874344
45. Vandenabeele P., Galluzzi L., Vanden Berghe T., Kroemer G, Molecular mechanisms of necroptosis: an ordered cellular explosion. Nat Rev Mol Cell Biol2010; 11: 700–;714. doi: 10.1038/nrm297020823910
46. Takahashi N., Duprez L., Grootjans S., Cauwels A., Nerinckx W., DuHadaway J.B., et al. Necrostatin-1 analogues: critical issues on the specificity, activity and in vivo use in experimental disease models. Cell Death Dis. 2012, 3:e437. doi: 10.1038/cddis.2012.17623190609
47. Larsson P., Elfsmark D., Svensson K., Wikström P., Forsman M., Brettin T., et al. Molecular evolutionary consequences of niche restriction in Francisella tularensis, a facultative intracellular pathogen. PLoS Pathog. 2009;5(6):e1000472. doi: 10.1371/journal.ppat.100047219521508
48. Karki R., Man S.M., Malireddi R.K., Gurung P., Vogel P., Lamkanfi M., et al. Concerted activation of the AIM2 and NLRP3 inflammasomes orchestrates host protection against Aspergillus infection. Cell Host Microbe. 2015; 17(3):357–;368. doi: 10.1016/j.chom.2015.01.00625704009
49. Barrigan L.M., Tuladhar S., Brunton J.C., Woolard M.D., Chen C.J., Saini D., et al. Infection with Francisella tularensis LVS clpB leads to an altered yet protective immune response. Infect Immun. 2013;81(6):2028–;42. doi: 10.1128/IAI.00207-1323529616
50. Summers C., Rankin S.M., Condlife A.M., Singh N., Peters A.M., Chilvers E.R, Neutrophil kinetics in health and disease. Trends Immunol. 2010; 31, 318–;324. doi: 10.1016/j.it.2010.05.00620620114
51. Nauseef W.M., Borregaard N, Neutrophils at work. Nat Immunol. 2014;15(7):602–;11. doi: 10.1038/ni.292124940954
52. Shigeoka A.A., Mueller J.L., Kambo A., Mathison J.C., King A.J., Hall W.F., et al. An inflammasome-independent role for epithelial-expressed Nlrp3 in renal ischemia-reperfusion injury. J Immunol. 2010;185(10):6277–;85. doi: 10.4049/jimmunol.100233020962258
53. Tran H.B., Lewis M.D., Tan L.W., Lester S.E., Baker L.M., Ng J., et al. Immunolocalization of NLRP3 Inflammasome in Normal Murine Airway Epithelium and Changes following Induction of Ovalbumin-Induced Airway Inflammation. J Allergy (Cairo). 2012;2012:819176.
54. Shahzad K., Bock F., Dong W., Wang H., Kopf S., Kohli S., et al. Nlrp3-inflammasome activation in non-myeloid-derived cells aggravates diabetic nephropathy. Kidney Int. 2015;87(1):74–;84. doi: 10.1038/ki.2014.27125075770
55. Peeters P.M., Perkins T.N., Wouters E.F., Mossman B.T., Reynaert N.L, Silica induces NLRP3 inflammasome activation in human lung epithelial cells. Part Fibre Toxicol. 2013;10(1):3.
56. Thinwa J., Segovia J.A., Bose S., Dube P.H, Integrin-mediated first signal for inflammasome activation in intestinal epithelial cells. J Immunol. 2014;193(3):1373–;82. doi: 10.4049/jimmunol.140014524965773
57. Czuprynski C.J., Henson P.M., Campbell P.A, Effect of dimethyl sulfoxide on the in vitro and in vivo bactericidal activity of human and mouse neutrophils and mononuclear phagocytes. Inflammation. 1984. 8(2):181–;916430803
58. Beilke M.A., Collins-Lech C., Sohnle P.G, Effects of dimethyl sulfoxide on the oxidative function of human neutrophils. J Lab Clin Med. 1987. 110(1):91–;63598341
59. Bruchard M., Rebé C., Derangère V., Togbé D., Ryffel B., Boidot R., et al. The receptor NLRP3 is a transcriptional regulator of TH2 differentiation. Nat Immunol. 2015;16(8):859–;70. doi: 10.1038/ni.320226098997
60. Gurung P., Karki R., Vogel P., Watanabe M., Bix M., Lamkanfi M., et al. An NLRP3 inflammasome-triggered Th2-biased adaptive immune response promotes leishmaniasis. J Clin Invest. 2015;125(3):1329–;38. doi: 10.1172/JCI7952625689249
61. Sutterwala F.S., Ogura Y., Szczepanik M., Lara-Tejeroet M., Litchenberger G.S., Grant E.P, et al. Critical role for NALP3/CIAS1/Cryopyrin in innate and adaptive immunity through its regulation of caspase-1. Immunity. 2006; 24, 317–;327. doi: 10.1016/j.immuni.2006.02.00416546100
62. Periasamy S., Singh A., Sahay B., Rahman T., Feustel P.J., Pham G.H., et al. Development of tolerogenic dendritic cells and regulatory T cells favors exponential bacterial growth and survival during early respiratory tularemia. J Leukoc Biol. 2011;90(3):493–;507. doi: 10.1189/jlb.041119721724804
63. Golde W., Gollobin P., Rodriguez L, A rapid, simple, and humane method for submandibular bleeding of mice using a lancet. Lab Anim (NY). 2005; 34:39–;43.